Royal Bank of Canada
BIVV

Royal Bank of Canada’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Royal Bank of Canada’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-217,496
Closed -$11.7M – 7203
2017
Q4 		$11.7M Buy
217,496
+113,758
+110% +$6.22M 0.01% 1502
2017
Q3 		$5.92M Buy
103,738
+44,123
+74% +$2.58M ﹤0.01% 1873
2017
Q2 		$3.59M Sell
59,615
-48,094
-45% -$2.74M ﹤0.01% 2181
2017
Q1 		$5.87M Buy
+107,709
New +$5.31M ﹤0.01% 1810

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Royal Bank of Canada's BIVV Position: Q1 2018 in Review

Royal Bank of Canada sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 217,496 shares — an estimated $11.7M sold.

Royal Bank of Canada first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $11.7M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Royal Bank of Canada reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Royal Bank of Canada sold 217,496 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $11.7M.
  • Royal Bank of Canada first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Royal Bank of Canada's Bioverativ Inc. Common Stock position peaked at $11.7M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Royal Bank of Canada's 13F filing for Q1 2018, filed 15 May 2018.